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The  asexual  erythrocytic phase  of the  development  of malaria  parasites  is 
responsible for the pathological manifestations of the disease in man. During the 
blood stage of infection, the parasite  develops within the erythrocytes (RBC) 1 
into three successive, morphologically distinct stages called ring forms, tropho- 
zoites, and schizonts.  Mature schizonts rupture  the  RBC, releasing merozoites 
which, after a short extracellular life in the blood, invade new RBC. 
Parasite components are exposed to the host immune effector mechanisms at 
the schizont stage, as parasite  components are exposed at the surface of RBC 
containing schizonts  (1-3),  and  at  the  merozoite  stage.  Immunization  experi- 
ments  have  therefore  been  conducted  in  monkeys susceptible  to  Plasmodium 
falciparum,  using whole schizonts and/or merozoites as immunogens (4-6).  The 
immunized monkeys were protected from a  lethal, blood-induced infection but 
most  of them  developed  a  moderate  transient  parasitemia.  The  usefulness of 
immunization with  whole  schizonts and/or  merozoites  is  limited, however,  by 
the contamination of these preparations  by potentially immunogenic RBC cell 
components (6).  This inconvenience may be avoided by using purified parasite 
components  as  immunogens.  Two  P. falciparum  polypeptides  were  therefore 
selected for immunization on the basis of several observations. They are among 
the four polypeptides recognized by monoclonal antibodies inhibiting the in vitro 
growth of asexual blood stages (200,000  [200  K],  140, 82, and 41  K mol wt) (3, 
7,  8);  they are  exposed as  intact polypeptides or as processed  products at  the 
surface of merozoites and/or schizonts (3, 9-11); and they are probably involved 
in the binding of merozoites to RBC (10). 
Material and Methods 
Preparation  of Schizont  and Merozoite Extract.  The SGE2  isolate of P. falciparum was 
adapted to in vitro culture using the blood of a patient from Zaire and was maintained in 
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culture  for  30  rno.  The  parasites  were cultivated  in  100-mm diam  Falcon petri  dishes 
using A+ human RBC (12). Cultures were initiated at a parasitemia of 0.4%, which varied 
between  12 and 20% after 4 d of culture.  Infected RBC from 40 dishes were harvested 
by centrifugation at  1,500 g for 15 min at 4°C.  A  brown upper layer present on top of 
each pellet was collected (~1/12 of the packed RBC), resuspended at a hematocrit of 50% 
with culture medium, and centrifuged at 1,500 g for 15 min in 1-ml Wintrobe tubes. The 
brown layer was collected again, resuspended in 20 vol of cold phosphate-buffered saline 
(PBS), and centrifuged at  1,500 g for 10 min. The pellet was extracted with 7 vol of lysis 
buffer (5 mM Tris,  50 mM  NaCl, 5  mM EDTA,  1%  Nonidet P-40 [NP-40], and 2  mM 
phenylmethylsulfonyl fluoride,  pH  7.2).  The lysate was centrifuged at 60,000 g  for 30 
min and the supernatant  was stored at -75°C.  This procedure was repeated nine times 
and provided 90 ml  of starting material.  The blood smears obtained on the last  pellet 
showed >85% schizonts, free merozoites, and pigments as well as trophozoites, rings, and 
normal RBC in low proportions. 
Preparation oflmmunoabsorbents.  IgG was purified by ammonium sulfate precipitation 
and  DEAE cellulose chromatography and then  coupled to cyanogen bromide-activated 
Sepharose 4B at a concentration of 20 mg/ml according to the manufacturer's specifica- 
tions  (Pharmacia  Fine  Chemicals,  Piscataway,  N  J).  Three  separate  immunoabsorbents 
were prepared  in  this  manner  using IgG from three  sources:  (a) a  pool of human sera 
from adults  living in  Gambia selected for their reactivity with polypeptides of 140 and 
200 K  tool wt (3);  (b) a pool of rabbit serum directed against human immunoglobulins, 
serum,  and  RBC  membranes  (DAKO,  Copenhagen,  Denmark);  and  (c)  rabbit  anti-P. 
falciparum  antisera (see below). 
[:~S]Methionine Labeling ofP. falciparum.  Unsynchronized SGE2 and FUP Palo Alto 
(13) isolates of P. falciparum  cultivated in  100-ram diam petri dishes at a parasitemia of 
15%  were resuspended  individually at a  hematocrit of 6% in methionine-free minimum 
essential  medium  (Eagle's;  Gibco  Laboratories,  Grand  Island,  NY)  supplemented  with 
10%  normal human serum,  40 mM  Hepes, and 2  mM glutamine.  L[sSS]methionine was 
added  at  a  concentration  of  100  uCi/ml  (sp  act  1,040  Ci/mmol;  Amersham  Corp., 
Arlington Heights, IL). After an incubation of 5 h in a candle jar at 37°C, the cells were 
washed twice in cold PBS and  the pellet  was extracted  with  12 vol of lysis buffer.  The 
lysate was centrifuged at 60,000 g for 30 rain at 4°C and aliquots were stored at -75°C. 
Preparation of Rabbit Anti-P. falciparum  Antisera.  20 ml of the P. falciparum  schizont 
and  merozoite  extract  were  supplemented  with  1  x  10 7  cpm  of an  extract  of SGE2 
L[35S]methionine-labeled P. falciparum  culture.  This extract was incubated overnight at 
4°C with 9 ml of Gambia IgG immunoabsorbent, poured into a column, and washed with 
5 vol of lysis buffer, followed by 2 vol of TNE (5 mM Tris, 50 mM NaC1,  5 mM EDTA), 
0.15%  NP-40 buffer. Elution was achieved at 4°C using 0.1  M glycine HC1,  0.15%  NP- 
40, pH  3.  One-milliliter  fractions were collected in  siliconized tubes,  immediately neu- 
tralized with 0.5 M Tris, pH 9, and checked for associated radioactivity using a Beckman 
LS20 13 counter (Beckman Instruments,  Inc., Fullerton,  CA) and for antigen content by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiog- 
raphy.  The eluted  fraction contained  four of the  main  merozoite- and schizont-specific 
antigens  of P. falciparum  (polypeptides  of  200,  160,  140,  and  82  K  tool  wt),  low 
concentrations of polypetides common to the  various asexual  development  stages,  and 
trace amounts of IgG and RBC membranes.  The antigenic fraction was dialyzed against 
distilled  water (using dialysis membranes boiled in  1%  SDS and then  in distilled  water), 
lyophilized, and  resuspended  in  2.5  ml of PBS containing 0.15%  NP-40.  The  IgG and 
RBC contaminants were removed by incubation with 4 ml of immunoabsorbent coupled 
with rabbit IgG directed against human lgG, human serum, and human RBC membrane. 
The 6  ml final preparation  contained 0.11  mg/ml of proteins as measured by a protein 
assay (Bio-Rad  Laboratories,  Richmond,  CA).  Two rabbits  were immunized four times 
with  0.5  ml  of the  malaria  antigenic  preparation  at  2-wk intervals,  the  first  time  with 
Freund's complete adjuvant and the following times with Freund's incomplete adjuvant. 
The serum of one of the rabbits had an endpoint titer of 1/32,000 by indirect immuno- 
fluorescence (14) and was used for the preparation of an immunoabsorbent. PERRIN  ET  AL.  443 
Purification  of the 200 and 140 K Mol Wt Polypeptides.  The same procedure as described 
above was repeated three times using for each purification 22 ml of P. falciparum extract 
supplemented with  108 cpm of an extract of L[3~S]methionine-labeled SGE2 P.falciparum. 
The supernatant was incubated and mixed on an end-over-end rotator overnight at 4°C 
with  25 ml of rabbit  IgG anti-P, falciparum  immunoabsorbent.  The acid-eluted fraction 
was dialyzed against H20 at 4°C for 24 h, lyophilized, and  reconstituted  in 2  ml of 20 
mM Tris, pH 8, containing 2% SDS and 3%/3-mercaptoethanol. 800 #1 of this preparation 
was applied  to 3-mm-thick, 200  X  160  mm,  6%  SDS-PAGE (procedure repeated  eight 
times) (15).  The  140 and  200  K  bands were identified on small  gel strips,  stained  with 
Coomassie Blue, excised with a razor blade, and electroeluted in a dialysis bag (16). The 
purity  of each  preparation  was  assessed  by  analysis  on  8%  SDS-PAGE  stained  with 
Coomassie Blue and by autoradiography. 
Tryptic  Digestion  and  Reverse  Phase  Chromatography  of  Malaria  Tryptic  Pep- 
tides.  Schizonts and merozoites were purified as described above using as starting material 
a  l-ml pellet of SGE2-parasitized RBC previously labeled with L[35S]methionine. The 200 
and  140 K tool wt enriched preparation was purified using the rabbit immunoabsorbent. 
This  preparation  was  applied  on  8%  SDS-PAGE  and  the  200  and  140  K  mol  wt 
polypeptides were visualized by autoradiography of the dried gel. The regions containing 
the labeled polypeptides were excised, eluted, and digested for 18 h at 37°C with 50 ul 
of TPCK trypsin (Worthington  Biochemical Corp.,  Freehold,  NJ) (17).  For the reverse 
phase chromatography of tryptic peptides, the peptides were dissolved for 10 min in  100 
#1 of 90% formic acid, and then diluted with 400 #1 of H~O. The sample was then applied 
to a 4.6-ram ×  25-cm Spherisorb  10 ODS (CI 8) reverse phase column (Spectra-Physics, 
Inc., Mountain  View, CA). The column was run at 40°C and at a  flow rate of 1.4 ml/ 
rain.  After injection of the sample, the column was washed for 5 min with 4.5%  formic 
acid (PSC reagents; J. T. Baker Chemical Co., Phillipsburg, N  J) and then developed with 
a  linear gradient from 0  to 62.5%  ethanol (Photrex reagent; J. T.  Baker Chemical Co.) 
in  4.5%  formic acid  over  three  periods  of 95  min  on  a  Spectra-Physics  SP8000  high 
performance  liquid  chromatography  system.  Aliquots  were  taken  from  each  of  the 
fractions selected and mixed with 6 vol of Aquasol (New England Nuclear, Boston, MA) 
for counting in a liquid scintillation counter. 
Animals  and  Immunization  Schedule.  Six  male  and  six  female  Saimiri  monkeys  of 
Guyana origin, mean age 3 yr 2 mo, weighing between  600 and 800 g, and bred in the 
animal facilities of Hoffmann-La Roche in Basel, were divided into three groups of two 
males and two females. These monkeys were free of parasites commonly detected in wild 
monkeys (Trypanosoma,  Leishmania,  Filaria).  The control group of four monkeys was 
injected subcutaneously three times in four different sites: the first time with 0.5 ml saline 
mixed with Freund's complete adjuvant, the second and third times with 0.5 ml of saline 
mixed with  0.5 ml of Freund's incomplete adjuvant  16 and 30 d, respectively, after the 
first immunization.  The second and third groups of animals were immunized according 
to the same protocol with the 200 or 140 K tool wt antigenic preparations,  using 30 #g 
of protein in a volume of 0.5 ml mixed with an equal volume of adjuvant. 
Challenge, Monitoring of the Infection, and the Antibody Response.  The 12 monkeys were 
challenged on day 63  by an intravenous injection  into the femoral vein with  2.5  x  107 
parasites provided by a splenectomized monkey infected 8 d previously with the Uganda 
Palo Alto strain  FUP of P. falciparum (gift of Dr. Hommel). Parasitemia was determined 
at various intervals on Giemsa-stained, thin blood smears. Before starting the experiment, 
it was decided to treat with antimalarial drugs any monkey with a parasitemia >20%. Sera 
collected at various intervals were checked for antimalarial antibody titers using an indirect 
immunofluorescence technique (14). For immunoprecipitation experiments,  4 x  10 ~ cpm 
of L[35S]methionine-labeled P. falciparum Palo Alto or SGE2 cultures solubilized with lysis 
buffer were incubated with 5 ~1 of the various monkey sera, and immune complexes were 
precipitated by protein A (11). The immunoprecipitates were analyzed on 8% SDS-PAGE 
and autoradiographed (11,  14). 444  EXPERIMENTAl,  IMMUNIZATION  WITH  HUMAN  MALARIA 
Results 
Isolation and Characterization of the 200 and 140 K Mol Wt Polypeptides.  It has 
previously been shown  that  the  200 and  140  K  tool wt polypeptides and  their 
processed products  are  schizont  and/or  merozoite  specific (3,  9-11).  400  and 
520 #g, respectively, of the 200 and the  140 K polypeptides were purified from 
starting  material  corresponding  to  11  ml  of packed  infected  RBC (1.1  x  10 ~ 
RBC) containing  85%  schizonts at  various  stages of maturation  (from  4  to  32 
nuclei) and  numerous  free  merozoites.  The  140 and  200  K polypeptides were 
detectable  in  the  starting  material  analyzed  on  optimally  loaded  SDS-PAGE 
stained with Coomassie Blue by comparing stained gel with autoradiography.  A 
single passage on the immunoabsorbent depleted the starting material of at least 
90% of the 200 and  140 K components, since they were no longer detectable on 
flow-through fractions analyzed on SDS-PAGE followed by autoradiography (not 
shown).  The  material  eluted  by  glycine  HC1  buffer  from  the  rabbit  anti-P. 
falciparum imntunoabsorbent contained mainly the 200,  140, and 76 K polypep- 
tides (Fig.  1). The second step of the purification (electrophoresis) gave a recovery 
of at  least 85% as measured by determination  on subsamples of the counts per 
minute applied and recovered. The number of molecules present per schizont is 
a  gross approximation  due to the heterogeneity of the schizont population  and 
the presence of free merozoites in the starting material and corresponds approx- 
imately to 3  x  104 molecules for the 200 K and 6  ×  104 molecules for the  140 
K polypeptide.  The  200  and  140  K  polypeptides used for immunization  were 
fi'ee of contaminants  as  shown  on  Fig.  1.  In  addition,  these  polypeptides still 
reacted after Western  blotting with  monoclonal antibodies directed against  the 
200  and  140  K  polypeptides  (data  not  shown).  To  investigate  the  structural 
relatedness  between the  200  and  I40  K  polypeptides, both  polypeptides were 
digested with TCPK trypsin and the peptides recovered were analyzed by reverse 
FIGURr  1.  Analysis by SDS-PAGE and autoradiography of P. falciparum  schizont and mer- 
ozoite extracts and affinity-purified and electroeluted polypeptides.  Samples were heated as 
described before application on  the gel,  and after electrophoresis the gel  was stained with 
Coomassie Blue, destained, and autradiographed. The schizont and merozoite extract used as 
starting material  for purification  was  supplemented  with  30,000  cpm  of Ll~S]methionine- 
labeled SGE2 culture extract before application. (la, 2a, 3a, 4a) Commassie-stained gel, (lb, 
2b, 3b, 4b) autoradiography. (1) Schizont and merozoite extract, (2) material eluted from the 
rabbit anti-P, falciparum  immunoabsorbent, (3)  140  K mol wt polypeptide electroeluted, (4) 
200 K polypeptide electroeluted.  Arrows indicate polypeptides of 200 and 140 K.  Reference 
molecular weights (Pharmacia) are indicated. PERRIN  ET  AL.  445 
phase chromatography.  As shown in Fig. 2, there is no clear homology between 
the peptide patterns of the 200 and  140 K polypeptides. 
The course of parasitemia  in the three groups of monkeys is reported on Fig. 
3.  Two of the control monkeys had to be treated with antimalarial  drugs when 
their parasitemia reached >20%. Two other monkeys of this group spontaneously 
recovered and  their  maximum  parasitemia  reached  9.5 and  11%, respectively. 
Due to a technical error one of these monkeys received a paravenous challenge 
infection  and  a  delay  of 7  d  was  observed  before  the  appearance  of patent 
parasitemia.  The  eight  monkeys  immunized  with  either  the  200  or  140  K 
polypeptides  spontaneously  cleared  their  parasites.  In  both  groups  a  delayed 
onset of patent parasitemia (defined here as a parasitemia >0.01%) was observed. 
In the group of monkeys immunized with the  140 K polypeptide, peak parasit- 
emia was <3% in three monkeys and reached 4.5% in one monkey. In the group 
immunized  with  the  200  K  polypeptide,  peak  parasitemia  was  <3%  in  two 
monkeys, reached 6% in one monkey, and  11% in another.  The latter monkey 
suffered  from  a  large  skin  excoriation  on  its  tail  that  appeared  after  the  first 
immmunization,  and  the  animal  lost  a  large  amount  of serous  fluid.  Weekly 
monitoring of blood smears from all the monkeys for 3 mo after challenge did 
not reveal recrudescent patent parasitemia.  The weight of the monkeys did not 
decrease  >5%  during  the  experiment  and  all  gained  weight  in  the  following 
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F]C,  tSaE  3.  Course of parasitemia in three groups of four monkeys immunized, respectively, 
with saline, 140 K polypeptide, and 200 K polypeptide. Abscissa gives the days after challenge 
with 2.5 x  107 asexual blood forms of the isolate Palo Alto. 
month. All monkeys showed a decrease of their hematocrit 13 d after challenge 
as compared with levels before the start of the experiment: 34 vs. 41%  for the 
200 K group, 30 vs, 39% for the  140  K group, and 28 vs. 39%  for the control 
group. A return to a normal hematocrit level was observed 1 mo after challenge. 
Reactivity of the Monkey Sera.  The humoral response of the immunized and 
control monkeys was tested by indirect imrnunofluorescence and immunoprecip- 
itation. None of the sera collected before immunization was positive by indirect 
immunofluorescence (Fig. 4). All but one of the sera of the monkeys immunized 
with the 200 and  140  K polypeptides were positive after the second immuniza- 
tion. The one negative serum was collected from the monkey immunized with 
the  200  K  polypeptide and suffering from a  large skin  excoriation. A  rise  in 
antimalarial antibody titers  was  observed  after  the  third  immunization in  all 
monkeys. Prechallenge sera of the monkeys immunized with the 200 and 140  K 
polypeptides reacted equally with schizonts and merozoites from the SGE2 isolate 
used for immunization, with the Palo Alto isolate used for challenge, and with 
three other isolates of P. falciparum  of Asian and South American origin. The 
sera collected after the second and third immunization were used for immuno- 
precipitation experiments. Sera  collected after the second immunization from 
monkeys immunized with the 200 or  140  K polypeptides only reacted with the 
polypeptides used for their immunization. A similar reactivity was observed using 
sera collected after the third immunization (Fig. 5) but an additional polypeptide 
of -31  K was precipitated by the four sera of the monkeys immunized with the 
200  K polypeptide. One of the sera of the monkeys immunized with the  140  K PERRIN  ET  AL. 
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FX(;URE 5.  [~aS]methionine-labeled polypeptides immunoprecipitated by prechallenge sera of 
two  monkeys  of the  control  group  (Nos.  9  and  10)  and  sera  from  each  of the  monkeys 
immunized with the  140 K polypeptide (Nos.  1-4) and with the 200 K polypeptide (Nos. 5- 
8).  No.  6  corresponds to  the sera (O) on  Figs.  3 and 4; this monkey suffered from a  large 
excoriation. Pf, starting material for immunoprecipitation: [sSS]methionine-labeled extract of 
SGE2 P. falciparum  isolate. Arrows indicate polypeptides of 200,  140, 39, and 31  K mol wt. 
The 31  K polypeptide is not clearly visible on this reproduction. 
polypeptide  precipitated  an  additional  polypeptide  with  an  apparent  relative 
molecular weight of 39,000.  Similar results were obtained by using [SSS]methio- 
nine material from SGE2 or Palo Alto isolates. 
Discussion 
In this study, immunization of Saimiri sciureus  monkeys with small amounts of 
merozoites and/or schizont polypeptides of P. falciparum conferred a significant 448  EXPERIMENTAI. IMMUNIZATION WITH  HUMAN MALARIA 
degree  of protection  against  a  blood-induced  challenge  infection.  The  eight 
immunized  monkeys survived an infection that induced a  life-threatening  situa- 
tion requiring drug therapy in two of the four control monkeys. The number of 
animals  in  the  control  group  is  relatively  small  but  in  other  experiments  con- 
ducted by the same investigators using the same experimental  protocol, similar 
results  were observed:  five out of nine  control  monkeys required  antimalarial 
therapy  after  reaching  a  parasitemia  >20%.  The  cause  of  the  variation  in 
susceptibility between individual  monkeys is not known but is unrelated  to sex, 
age, weight, and origin of the monkeys. 
The sera of the monkeys immunized with either the 200 or the  140 K mol wt 
polypeptides had  a  relatively  good prechallenge  antibody titer as measured  by 
Freund's incomplete adjuvant and strongly precipitated the polypeptide used for 
their immunization.  The main conclusion of this investigation is that immuniza- 
tion  with  limited  amounts  of defined  and  possibly  denatured  P. falciparum 
polypeptides induces  in  monkeys a  degree  of resistance  at  least  equal  to  that 
obtained in monkeys immunized  with whole schizonts and/or merozoites (4, 6). 
Other  studies  (18,  19)  have  previously shown,  using  malaria  species infecting 
rhesus  monkeys  and  mice,  that  defined  antigens  are  indeed  able  to  raise  a 
protective immune response. These data present an interesting step towards the 
development of a malaria  vaccine, since identified antigens may be produced in 
the future by DNA recombinant technology or direct biochemical synthesis (20). 
The mechanism of protection induced by immunization with purified polypep- 
tides  from  merozoites  and/or  schizonts  is  difficult  to  elucidate  because,  in 
vaccinated monkeys, low to substantial levels of parasitemia persisted for at least 
15 d,  suggesting that  reinvasion  continued.  It may be that  the level of specific 
antibodies  induced  by the  low amount  of probably modified  antigen  was not 
fully adequate.  There are at least three other alternatives.  First,  antibodies are 
only one major element needed to achieve protection and may play a crucial role 
in  the  early  control  of parasite  multiplication.  Complete  elimination  of  the 
malaria parasite,  however, may depend on cellular immune response (21), mac- 
rophage activation (22), and/or cytokine production (23, 24) and these responses 
may be delayed or induced by antigens different from those responsible for an 
antibody-dependent protective response.  Secondly, antigenic diversity has been 
shown to occur among and within various isolates of P. falciparum (25, 26). It is 
therefore possible that  only some of the antibodies raised against  the antigens 
used  for  immunization  are  effective.  In  the  experiment  reported  here,  the 
protective  effect crossed different  isolates  of P. falciparum,  since  the  purified 
polypeptides were obtained from an isolate (SGE2) unrelated to the isolate (Palo 
Alto) used for challenge.  Finally, the parasite  itself modifies the hosts'  immune 
responses and this may also account for the inability to induce a sterile immunity 
(27). 
Sera from monkeys immunized with the 200 and  140 K mol wt polypeptides 
reacted only with the polypeptide used for immunization,  suggesting that these 
two polypeptides did not share major antigenic determinants.  However, a recent 
study indicates that a  195 K mol wt P. falciparum polypeptide was processed into 
smaller molecular weight products at the end of schizogony (11). The relatedness 
of the 200 and  140 K polypeptides was therefore investigated; there is no clear PERRIN  ET  AL.  449 
homology in the profile of peptides obtained after trypsin digestion of both the 
200  and  140  K  polypeptides.  This  result  is  in  agreement  with  a  study  (28) 
demonstrating  that a probable analogue of the  140 K P. falciparum polypeptide 
expressed at  the  surface of P.  knowlesi  merozoites  is antigenically  unrelated  to 
other  merozoite  surface  components.  It  seems,  therefore,  that  at  least  two 
different  surface  components  of P. falciparum  and  possibly others  (the  41  K 
polypeptide is also a  good candidate)  may induce a partial protective immunity 
against P. falciparum asexual blood stages. 
Summary 
Plasmodium falciparum polypeptides of 200 and  140 K mol wt exposed at the 
surface of merozoites and/or schizonts were purified by affinity chromatography 
and  by electroelution  from  sodium  dodecyl sulfate-polyacrylamide gel electro- 
phoresis.  Monkeys were  separated  into  three  groups  of four and  immunized 
either with one of the two polypeptides or with saline (control). After intravenous 
challenge with 2.5 x  107 P. falciparum asexual blood stages, two monkeys of the 
control  group  had  to  be treated  and  two recovered  spontaneously  after  peak 
parasitemia  of 9  and  11%.  The  four  monkeys  immunized  with  the  140  K 
polypeptide  recovered  without  treatment  after  peak  parasitemia  between  1.5 
and  4.5%.  Monkeys immunized  with  the  200  K  polypeptide had  similar  peak 
parasitemia except one monkey who suffered from a large skin excoriation and 
who recovered spontaneously after a peak parasitemia of 11%. Prechallenge sera 
of the immunized monkeys reacted only with the polypeptide used for immuni- 
zation except for one serum of the 140 K group, which precipitated an additional 
polypeptide of 39 K, and a polypeptide of 31  K weakly precipitated by the four 
sera of monkeys immunized with the 200 K polypeptide. 
The  relatedness  between  the  200  and  140  K  polypeptides was investigated 
using tryptic digestion and reverse phase chromatography. No clear analogy was 
found  between  the  two  polypeptides,  which  suggests  that  immunization  with 
either  of two independent  surface components of P. falciparum  asexual  blood 
stages is able to induce at least a partial protective immunity in immunized hosts. 
We thank Mrs. I. Callegari,  B. Scherz, and E. Ramirez  for their excellent technical  help 
and Mrs. M. Devouge for help in preparing the manuscript. 
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